NEWS RELEASE March 18, 2014 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD AMENDS ITS LIST OF CONTROLLED THERAPEUTIC MEDICATIONS IN AN EFFORT TO ADVANCE THE REFORM MOVEMENT, COMMITS SIGNIFICANT FUNDS TO 2014 TACTICAL RESEARCH INITIATIVES The board of directors of the Racing Medication and Testing Consortium (RMTC) held a regular meeting March 17 in
NEWS RELEASE December 3, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC: CURRENT THRESHOLD LEVELS FOR CORTICOSTEROIDS, CLENBUTEROL SHOULD REMAIN The Racing Medication & Testing Consortium (RMTC) is releasing two position papers which stated that no physiologic difference among the various racing breeds exists to justify changing regulatory thresholds from those recently established by the
NEWS RELEASE October 17, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC TACTICAL RESEARCH PROGRAM IDENTIFIES SUBSTANCES IN ROBERSON CASE FOR DELAWARE RACING COMMISSION The RMTC Tactical Research Program was instrumental in the Delaware Thoroughbred Racing Commission’s recent prosecution of Donald Roberson by working with the HFL Sport Science -Lexington laboratory to identify dichloracetic acid
NEWS RELEASE September 20, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD: STANOZOLOL THRESHOLD ELIMINATED, OHIO STATE LAB GRANTED INTERIM ACCREDITATION, UNIFORM NATIONAL MEDICATION RULES, PENALTIES AND LAB REFORMS ENDORSED, OUT OF COMPETITION TESTING COMMITTEE FORMED, WALDROP ELECTED TO SUCCEED LEWIS AS CHAIRMAN The board of directors of the Racing Medication and Testing Consortium
NEWS RELEASE July 19, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC GIVES FINAL APPROVAL FOR MULTIPLE VIOLATION PENALTY MODEL RULE The Racing Medication and Testing Consortium (RMTC) board of directors has given final approval for a Multiple Violation Penalty (MVP) model rule and has forwarded it to the Association of Racing Commissioners International (RCI)
NEWS RELEASE July 2, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC ISSUES DRUG BULLETINS ON PURPLE PAIN AND TB-500 The Racing Medication and Testing Consortium (RMTC) Tactical Research Committee has reviewed data from laboratory analysis of two substances of concern in racing that have been marketed as powerfully effective drugs – “Purple Pain” and
NEWS RELEASE June 13, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC ACCREDITS FIRST TWO LABORATORIES Lexington, KY -- The University of California-Davis Kenneth L. Maddy Laboratory and HFL Sport Science Inc., Lexington, Ky., became the first two fully-accredited laboratories under the RMTC Laboratory Accreditation program Tuesday. “The accreditation of these two laboratories marks the
NEWS RELEASE June 6, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC APPROVES MULTIPLE VIOLATION PENALTY SYSTEM A new penalty system for North American racing designed to reduce positive drug tests and identify and penalize trainers with multiple medication infractions took a major step toward implementation this week when the Racing Medication and Testing Consortium
NEWS RELEASE March 21, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD RECOMMENDS THERAPEUTIC WITHDRAWAL TIMES, GRANTS FIRST INTERIM LAB ACCREDITATION At its March 19 meeting in Baltimore, Maryland, the Racing Medication and Testing Consortium (RMTC) board of directors adopted recommendations for thresholds and withdrawal times for four therapeutic medications identified by the Association
NEWS RELEASE January 25, 2013 Contact: Hallie Lewis (859) 224-2848 RMTC REPORTS OVERALL DECREASE IN PHENYLBUTAZONE VIOLATIONS IN JURISDICTIONS THAT ADOPTED 2 MICROGRAM THRESHOLD A recent Racing Medication and Testing Consortium (RMTC) review of violation records from nine states that lowered their phenylbutazone threshold from 5 micograms per milliliter of plasma to the RMTC-recommended level
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
